None listed
Conditions
Interventions
Intervention1: Yoga: Validated yoga module for 1 year
1hr/day 5 days a week
Control Intervention1: NA: NA
Control Intervention2: Walking exercise: NA
Sponsors
DST SATYAM
Eligibility
Inclusion criteria
Inclusion criteria: 1. Willing to participate in the interventions 2. No presence of implanted devices or metallic bodies above the waist 3. No history of stroke or Transient ischemic attack (TIA) 4. Intention to remain in the local area for the duration of the intervention or testing period
Exclusion criteria
Exclusion criteria: 1. Clinically advised not to perform exercises 2. Prior exposure to Yoga; involved in current or recent (last two months) practice of yoga or those with regular (three times per week or more) participation in other planned exercises, such as aerobics or strength training 3. Known accelerated hypertension 4. Overt clinical congestive heart failure requiring treatment with a diuretic or angiotensin converting enzyme inhibitor. 5. Renal failure (serum creatinine of more than 150 µmol/l) 6. Condition expected to severely limit survival, e.g. terminal illness 7. Clinical diagnosis of dementia 8. Resident in a nursing home, i.e. where the dependency and care requirements of the patients are such that they require the regular input of qualified nurses and therefore the majority of staff in the home are nurses (other forms of residential care are acceptable). 9. Unable to stand up or walk 10. Participation in a drug trial within the past month preceding selection. 11. Alcohol or drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| KDM-based BA estimates Albumin, blood urea nitrogen, creatinine, C-reactive protein, cytomegalovirus optical density, glycated hemoglobin, total cholesterol, white blood cell count, lymphocyte percent, mean corpuscular volume, and systolic blood pressureTimepoint: 3 time points Baseline 6th month 12th month | — |
Secondary
| Measure | Time frame |
|---|---|
| IL-6,TNF alpha-receptor II, CRP, GDF15, insulin, IGF1, cystatin C, NT-proBNP, hemoglobin A1c. Walk-speed test, grip-strength, forced expiratory volume test, Balance, Quality of life, Loneliness scale and cognitionTimepoint: 3 time points Baseline 6th month 12th month | — |
Countries
India
Contacts
Public ContactVijaya Majumdar
SVYASA Deemed to be University
Outcome results
None listed